Bank of America’s Adagio Medical Holdings ADGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.51K Sell
11,531
-1,326
-10% -$1.3K ﹤0.01% 5648
2026
Q1
$14.8K Buy
12,857
+1,363
+12% +$1.38K ﹤0.01% 5662
2025
Q4
$12K Buy
11,494
+11,465
+39,534% +$13.6K ﹤0.01% 6129
2025
Q3
$56 Sell
29
-4
-12% -$6 ﹤0.01% 7985
2025
Q2
$43 Buy
33
+1
+3% +$1 ﹤0.01% 8134
2025
Q1
$26 Buy
32
+3
+10% +$3 ﹤0.01% 8088
2024
Q4
$30 Buy
29
+10
+53% +$24 ﹤0.01% 7957
2024
Q3
$49 Buy
+19
New +$90 ﹤0.01% 7842

Other funds holding ADGM

Bank of America's ADGM Position: Q2 2026 in Review

Bank of America reduced its Adagio Medical Holdings (ADGM) stake by 10% in Q2 2026, selling an estimated $1.3K and leaving 11,531 shares worth $7.51K. The position accounts for ﹤0.01% of the portfolio, ranked #5648.

Bank of America first reported a position in ADGM in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.8K in Q1 2026. 24 funds tracked by Wall St. Rank hold ADGM as of Q2 2026.

  • Bank of America held 11,531 shares of Adagio Medical Holdings worth $7.51K as of Q2 2026.
  • Bank of America sold 1,326 Adagio Medical Holdings shares in Q2 2026, an estimated $1.3K.
  • Adagio Medical Holdings made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #5648 holding.
  • Bank of America first reported a position in Adagio Medical Holdings in Q3 2024 and has held it in 8 quarters since.
  • Bank of America's Adagio Medical Holdings position peaked at $14.8K in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Adagio Medical Holdings as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.